Compare NRT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRT | ECOR |
|---|---|---|
| Founded | 1975 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 85.6M |
| IPO Year | 1995 | 2018 |
| Metric | NRT | ECOR |
|---|---|---|
| Price | $9.09 | $9.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 39.9K | ★ 95.4K |
| Earning Date | 05-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 10.18% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $21.21 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $4.99 | $4.41 |
| 52 Week High | $10.49 | $10.95 |
| Indicator | NRT | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 56.76 |
| Support Level | $8.48 | $5.70 |
| Resistance Level | $9.52 | $10.60 |
| Average True Range (ATR) | 0.25 | 0.80 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 85.54 | 43.30 |
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.